Wang Xiaolin
SEC CIK 1849181 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | See Remarks | 116.1K | — | $275.8K | 14 | 2021-09-17 | 2026-03-17 |
Most active insiders at RVMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOLDSMITH MARK A | See Remarks, Dir | — | $56.99M |
| 2 | Kelsey Stephen Michael | See Remarks | — | $22.55M |
| 3 | Cislini Jeff | SVP, GC | — | $15.19M |
| 4 | Kim Lorence H. | Dir | — | $14.97M |
| 5 | Horn Margaret A | COO | — | $10.84M |
| 6 | Mancini Anthony | See Remarks | — | $9.05M |
| 7 | Anders Jack | CFO | — | $7.13M |
| 8 | ANDERSON ELIZABETH M | Dir | — | $1.96M |
| 9 | Patel Sushil | Dir | — | $1.05M |
| 10 | Wei Lin | Chief Medical Off | — | $206.2K |
| 11 | Wang Xiaolin | See Remarks | — | $200.0K |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-03-19 | 2026-03-17 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | S - Sale | $99.48 | -2,010 | 116.1K | -2% | -$200.0K |
| D | 2026-03-03 | 2026-03-01 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | A - Grant | $0.00 | +15.1K | 118.1K | +15% | $0 |
| 2025-03-19 | 2025-03-17 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | G - Gift | $0.00 | -2,718 | 102.3K | -3% | $0 | |
| D | 2025-03-04 | 2025-03-01 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | A - Grant | $0.00 | +19.0K | 105.0K | +22% | $0 |
| D | 2024-03-05 | 2024-03-01 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | A - Grant | $0.00 | +24.2K | 84.5K | +40% | $0 |
| 2023-03-21 | 2023-03-17 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | S - Sale | $21.78 | -714 | 58.8K | -1% | -$15.6K | |
| D | 2023-03-03 | 2023-03-01 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | A - Grant | $0.00 | +29.0K | 59.5K | +95% | $0 |
| 2022-12-21 | 2022-12-19 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | S - Sale | $22.94 | -708 | 30.5K | -2% | -$16.2K | |
| 2022-09-21 | 2022-09-19 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | S - Sale | $19.04 | -735 | 31.2K | -2% | -$14.0K | |
| 2022-06-22 | 2022-06-17 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | S - Sale | $17.75 | -665 | 32.0K | -2% | -$11.8K | |
| 2022-03-21 | 2022-03-17 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | S - Sale | $18.61 | -240 | 31.7K | -0.8% | -$4,466 | |
| D | 2022-03-03 | 2022-03-01 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | A - Grant | $0.00 | +20.0K | 31.9K | +168% | $0 |
| 2021-12-21 | 2021-12-17 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | S - Sale | $24.41 | -257 | 11.9K | -2% | -$6,273 | |
| 2021-09-21 | 2021-09-17 | RVMD | Revolution Medicines, Inc. | Wang Xiaolin | See Remarks | S - Sale | $30.02 | -250 | 12.2K | -2% | -$7,505 |
Purchase Sale Sale after option exercise All abbreviations